Irritant contact dermatitis during COVID-19 : preventing the virus while keeping the itch at bay

Show simple item record

dc.contributor.author Cordier, Werner
dc.date.accessioned 2022-07-29T07:00:41Z
dc.date.available 2022-07-29T07:00:41Z
dc.date.issued 2021-08
dc.description.abstract Hand hygiene practices have been bolstered during the COVID-19 pandemic to curb the spread of SARS-CoV-2. Unfortunately, such prevention strategies come with a risk of excessive physical damage to the skin and exposure to dermatological irritants, including soap, alcohol, and surfactants. Irritant contact dermatitis frequency has increased not only among those typically susceptible to it, such as healthcare workers, but also among the general populace. This report briefly discusses some of the most common implicated irritants, as well as guidelines and measures for mitigating dermatitis, which include dermatological treatments ranging from moisturisers to pharmacotherapy. Hand hygiene practices may not change, but by following good preventative guidelines and appropriate pharmacotherapeutic interventions, irritant contact dermatitis can be controlled. en_US
dc.description.department Pharmacology en_US
dc.description.uri http://www.sapj.co.za en_US
dc.identifier.citation Cordier, W. 2021, 'Irritant contact dermatitis during COVID-19 : preventing the virus while keeping the itch at bay', SA Pharmaceutical Journal, vol. 88, no. 4, pp.24-28, doi : 10.520/ejc-mp_sapj_v88_n4_a7. en_US
dc.identifier.issn 2221-5875 (print)
dc.identifier.issn 2220-1017 (online)
dc.identifier.other 10.520/ejc-mp_sapj_v88_n4_a7
dc.identifier.uri https://repository.up.ac.za/handle/2263/86583
dc.language.iso en en_US
dc.publisher Medpharm Publications en_US
dc.rights © Medpharm. This article is licensed under a This article is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 2.5 South Africa License. en_US
dc.subject Irritant contact dermatitis en_US
dc.subject Moisturisers en_US
dc.subject Topical calcineurin inhibitors en_US
dc.subject Topical corticosteroids en_US
dc.subject COVID-19 pandemic en_US
dc.subject Coronavirus disease 2019 (COVID-19) en_US
dc.subject Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) en_US
dc.title Irritant contact dermatitis during COVID-19 : preventing the virus while keeping the itch at bay en_US
dc.type Article en_US


Files in this item

This item appears in the following Collection(s)

Show simple item record